Journey Medical (DERM) Intangibles (2020 - 2026)

Journey Medical has reported Intangibles for 7 years, with the latest figure at $26.5 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 14.02% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $26.5 million (down 14.02% YoY), and the FY2025 full-year result was $27.6 million, down 13.36% from the prior year.
• Intangibles for Q1 2026 stood at $26.5 million, down from $27.6 million in the prior quarter.
• The five-year high for Intangibles was $31.9 million in Q4 2024, with the low at $17.8 million in Q3 2024.
• Historically, Intangibles has averaged $25.7 million across 5 years, with a median of $27.2 million in 2022.
• Annual changes were most pronounced in 2022 — Intangibles surged 117.93% — and 2023, when it declined 25.76%.
• Journey Medical's Intangibles stood at $27.2 million in 2022, then decreased by 25.41% to $20.3 million in 2023, then jumped by 57.06% to $31.9 million in 2024, then fell by 13.36% to $27.6 million in 2025, then dropped by 4.08% to $26.5 million in 2026.
• The last three Intangibles figures came in at $26.5 million (Q1 2026), $27.6 million (Q4 2025), and $28.7 million (Q3 2025), per Business Quant data.